{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:02:18Z","timestamp":1793995338190,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012580","name":"Natural Science Foundation of Tianjin Science and Technology Correspondent Project","doi-asserted-by":"publisher","award":["22ZYJDSS00070"],"award-info":[{"award-number":["22ZYJDSS00070"]}],"id":[{"id":"10.13039\/501100012580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["21JCQNJC01470"],"award-info":[{"award-number":["21JCQNJC01470"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22073070"],"award-info":[{"award-number":["22073070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A2089"],"award-info":[{"award-number":["U23A2089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jconrel.2023.12.022","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T03:53:18Z","timestamp":1704253998000},"page":"204-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer"],"prefix":"10.1016","volume":"366","author":[{"given":"Wenyan","family":"She","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.12.022_bb0005","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S0305-7372(10)70025-6","article-title":"Treatment of triple negative breast cancer (TNBC): current options and future perspectives","volume":"36","author":"Laurentiis","year":"2010","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0010","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s12668-022-00991-1","article-title":"Triple-negative breast cancer: the current aspects of pathogenesis and therapies","volume":"12","author":"Mani","year":"2022","journal-title":"BioNanoScience"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijc.33781","article-title":"Metabolic checkpoints and novel approaches for immunotherapy against cancer","volume":"150","author":"Li","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0020","first-page":"44","article-title":"Metabolic reprogramming in triple-negative breast cancer, Cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0025","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s42003-021-02805-8","article-title":"DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer","volume":"4","author":"Shen","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0030","doi-asserted-by":"crossref","first-page":"eaav0936","DOI":"10.1126\/scitranslmed.aav0936","article-title":"Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state","volume":"11","author":"Echeverria","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","article-title":"Metabolic interactions in the tumor microenvironment","volume":"27","author":"Lyssiotis","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101174","article-title":"Targeting immune cells for cancer therapy","volume":"25","author":"Gun","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jconrel.2022.12.003","article-title":"Targeting glycolysis for cancer therapy using drug delivery systems","volume":"353","author":"Huang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jconrel.2023.05.024","article-title":"Y, Huang, Targeting lactate metabolism and immune interaction in breast tumor via protease-triggered delivery","volume":"358","author":"Zhao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0065","article-title":"Insights into the effect of catalytic intratumoral lactate depletion on metabolic reprogramming and immune activation for antitumoral activity","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0070","doi-asserted-by":"crossref","first-page":"12642","DOI":"10.1038\/ncomms12642","article-title":"Reprogramming metabolic pathways in vivo with CRISPR\/Cas9 genome editing to treat hereditary tyrosinaemia","volume":"7","author":"Pankowicz","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol. Res."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115449","article-title":"CRISPR\/Cas genome editing in triple negative breast cancer: current situation and future directions","volume":"209","author":"Fu","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0085","first-page":"2384","article-title":"CRISPR\/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer, Comput. Struct","volume":"19","author":"Singh","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/cbin.11975","article-title":"Lactate: a pearl dropped in the ocean-an overlooked signal molecule in physiology and pathology","volume":"47","author":"Wu","year":"2023","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.12.035","article-title":"Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer","volume":"358","author":"Augoff","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Martinez-Reyes","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213268","article-title":"Metal-organic framework for biomimetic nitric oxide generation and anticancer drug delivery","volume":"145","author":"Ji","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0155","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/acsbiomaterials.9b01771","article-title":"Low-temperature trigger nitric oxide nanogenerators for enhanced mild photothermal therapy","volume":"6","author":"You","year":"2020","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.solmat.2020.110442","article-title":"Synthesis of therminol-based plasmonic nanofluids with core\/shell nanoparticles and characterization of their absorption\/scattering coefficients","volume":"209","author":"Lee","year":"2020","journal-title":"Sol. Energy Mater. Sol. Cells"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2020-139982","article-title":"Pyruvate dehydrogenase inhibition leads to decreased glycolysis and increased reliance on gluconeogenesis in acute myeloid leukemia","volume":"136","author":"Anderson","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41392-023-01320-y","article-title":"Metabolic interaction: tumor-derived lactate inhibiting CD8+ T cell cytotoxicity in a novel route","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266601","article-title":"Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism","volume":"17","author":"Kumstel","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0130","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1007\/s00432-022-04333-2","article-title":"A novel organic arsenic derivative MZ2 remodels metabolism and triggers mtROS-mediated apoptosis in acute myeloid leukemia","volume":"149","author":"Chen","year":"2023","journal-title":"J. Cancer Res. Clin."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2019.11.013","article-title":"The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia","volume":"146","author":"Zhang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1054\/bjoc.1999.0942","article-title":"Novel therapeutic approach: organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo","volume":"82","author":"Koshiuka","year":"2000","journal-title":"Brit. J. cancer"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0145","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1021\/acs.jmedchem.3c01197","article-title":"Reprogramming energy metabolism with synthesized PDK inhibitors based on dichloroacetate derivatives and targeted delivery systems for enhanced cancer therapy","volume":"66","author":"She","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1208\/s12249-021-02174-9","article-title":"Advances in delivery of chemotherapeutic agents for cancer treatment","volume":"23","author":"Yadav","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0165","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/anie.201610682","article-title":"Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like\/gas therapy","volume":"56","author":"Fan","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biotechadv.2018.11.009","article-title":"A comprehensive review on histone-mediated transfection for gene therapy","volume":"37","author":"Han","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0175","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/acsmaterialslett.2c00617","article-title":"Homologous targeting cascade nanobioreactor for autophagy inhibition amplified tumor catalytic therapy","volume":"5","author":"Wei","year":"2023","journal-title":"ACS Mater. Lett."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mattod.2015.11.025","article-title":"Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery","volume":"19","author":"Mo","year":"2016","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2021.12.264","article-title":"Post-translational modifications on mitochondrial metabolic enzymes in cancer","volume":"179","author":"Peng","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0195","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1007\/s12274-022-5340-0","article-title":"RNA sequencing-based optimization of biological lipid droplets for sonodynamic therapy to reverse tumor hypoxia and elicit robust immune response","volume":"16","author":"Shi","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0200","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2002-08-2512","article-title":"Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents","volume":"101","author":"Zhou","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0205","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: from genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41392-021-00595-3","article-title":"Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102065","article-title":"Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions","volume":"46","author":"Ying","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0220","doi-asserted-by":"crossref","first-page":"2100292","DOI":"10.1002\/advs.202100292","article-title":"Programmable unlocking nano-matryoshka-CRISPR precisely reverses immunosuppression to unleash cascade amplified adaptive immune response","volume":"8","author":"Yang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0225","first-page":"3835","article-title":"Tumor metabolism: cancer cells give and take lactate","volume":"118","author":"Semenza","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0230","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1039\/D2CS00479H","article-title":"Engineering lactate-modulating nanomedicines for cancer therapy","volume":"52","author":"Chen","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202101861","article-title":"pH-triggered aggregation of gold nanoparticles for enhanced labeling and long-term CT imaging tracking of stem cells in pulmonary fibrosis treatment","volume":"17","author":"Yu","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0240","doi-asserted-by":"crossref","first-page":"17287","DOI":"10.1021\/acsami.5b04359","article-title":"Facile synthesis of gold nanospheres modified by positively charged mesoporous silica, loaded with near-infrared fluorescent dye, for in vivo X-ray computed tomography and fluorescence dual mode imaging","volume":"7","author":"Song","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.12.022_bb0245","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e8","article-title":"Human CD8+ T-cell populations that express natural killer receptors","volume":"23","author":"Koh","year":"2023","journal-title":"Immune Netw."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114164","article-title":"LDHA as a regulator of T cell fate and its mechanisms in disease","volume":"158","author":"Dai","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.12.022_bb0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:43:50Z","timestamp":1777509830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923008064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":51,"alternative-id":["S0168365923008064"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.022","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}